Ethypharm

Ethypharm
International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.
About
What does Ethypharm do?
Ethypharm is a leading international specialty pharmaceutical company focused on manufacturing and providing essential medicines for Central Nervous System disorders, including severe pain and addiction, and for Hospital Injectables. The company is committed to improving patients' lives by addressing critical care situations and unmet needs in these core areas. Ethypharm serves patients and healthcare professionals globally, with a strategy for geographical expansion and a focus on growth.
What is Ethypharm's revenue?
StartupHub estimates Ethypharm's annual revenue at $74K (range $21K to $319K, 33% confidence), based on comparable companies in the sector.
What is Ethypharm's valuation?
StartupHub estimates Ethypharm's effective valuation at $3.9B (range $1.0B to $9.8B, 46% confidence), based on comparable companies in the sector.
How much funding has Ethypharm raised?
Ethypharm has raised a total of $557K in funding. The most recent round on record is Grant.
Where is Ethypharm headquartered?
Ethypharm is headquartered in Saint-Cloud, France.
When was Ethypharm founded?
Ethypharm was founded in 1977.
What industry does Ethypharm operate in?
Ethypharm operates in Pharmaceuticals, Life Sciences, Drug Discovery.
No comments yet. Be the first to share your take.
